Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a new revision note, v3.5.0, and the previous revision note, v3.4.3, was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:23:43.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 tag; removed the prior funding/operating-status notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:15.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Site-wide notice about funding and data currency has been added, indicating the NIH Clinical Center is open and where to find operating status updates. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:33:01.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and new headers 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' along with 'No FEAR Act Data'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:27:38.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This represents a minor site-version update and does not alter the study details, eligibility criteria, or user interactions.
    Difference
    0.1%
    Check dated 2026-01-14T03:37:16.000Z thumbnail image

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.